Stockscreener 앱 받기
26.45
1.05%
-0.28
시간 외 거래:
26.45
전일 마감가:
$26.73
열려 있는:
$26.72
하루 거래량:
606.83K
Relative Volume:
0.94
시가총액:
$1.19B
수익:
$681.75M
순이익/손실:
$70.47M
주가수익비율:
18.24
EPS:
1.45
순현금흐름:
$173.19M
1주 성능:
-0.82%
1개월 성능:
+17.35%
6개월 성능:
+12.51%
1년 성능:
+80.18%
1일 변동 폭
$26.23
$26.94
1주일 범위
$26.23
$27.64
52주 변동 폭
$12.61
$27.98
Pacira Biosciences Inc Stock (PCRX) Company Profile
명칭
Pacira Biosciences Inc
전화
650-242-8052
주소
2000 SIERRA POINT PARKWAY, BRISBANE, NJ
PCRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PCRX
Pacira Biosciences Inc
|
26.45 | 1.20B | 681.75M | 70.47M | 173.19M | 1.45 |
|
ZTS
Zoetis Inc
|
153.32 | 67.90B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.40 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.80 | 44.04B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.95 | 21.20B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
400.52 | 17.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Pacira Biosciences Inc Stock (PCRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-25 | 업그레이드 | Truist | Hold → Buy |
| 2025-01-30 | 업그레이드 | Truist | Sell → Hold |
| 2024-08-13 | 다운그레이드 | Truist | Buy → Sell |
| 2024-08-12 | 다운그레이드 | JP Morgan | Overweight → Underweight |
| 2024-08-12 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-08-12 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-08-12 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2024-07-03 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2024-03-07 | 재개 | JP Morgan | Overweight |
| 2023-12-20 | 개시 | Raymond James | Outperform |
| 2023-08-03 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2023-01-31 | 재개 | Wedbush | Outperform |
| 2022-10-21 | 재개 | Jefferies | Buy |
| 2022-01-03 | 재개 | JP Morgan | Overweight |
| 2021-07-26 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-04-21 | 재개 | JP Morgan | Neutral |
| 2021-04-09 | 개시 | Berenberg | Buy |
| 2021-04-07 | 재개 | RBC Capital Mkts | Outperform |
| 2021-02-11 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
| 2021-01-21 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-09-21 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2020-07-06 | 재확인 | Needham | Buy |
| 2020-05-27 | 개시 | Guggenheim | Neutral |
| 2020-04-07 | 개시 | Northland Capital | Outperform |
| 2020-03-20 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2020-02-24 | 재확인 | H.C. Wainwright | Buy |
| 2020-01-24 | 개시 | SunTrust | Buy |
| 2020-01-23 | 개시 | SunTrust | Buy |
| 2019-11-06 | 개시 | BTIG Research | Buy |
| 2019-06-11 | 개시 | Barclays | Overweight |
| 2019-05-06 | 업그레이드 | Mizuho | Underperform → Neutral |
| 2019-05-02 | 업그레이드 | Stifel | Sell → Hold |
| 2019-02-01 | 다운그레이드 | Mizuho | Neutral → Underperform |
| 2018-08-06 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2018-04-09 | 재확인 | H.C. Wainwright | Buy |
| 2018-03-21 | 재확인 | Mizuho | Neutral |
| 2018-02-16 | 다운그레이드 | Needham | Buy → Hold |
| 2018-01-19 | 개시 | Seaport Global Securities | Buy |
| 2018-01-04 | 재확인 | Canaccord Genuity | Buy |
| 2018-01-03 | 개시 | Leerink Partners | Mkt Perform |
모두보기
Pacira Biosciences Inc 주식(PCRX)의 최신 뉴스
Predicting Pacira BioSciences Inc. trend using moving averagesJuly 2025 Weekly Recap & Technical Buy Zone Confirmations - Newser
Chart based exit strategy for Pacira BioSciences Inc.Swing Trade & Reliable Intraday Trade Plans - Newser
Is Pacira BioSciences Inc. impacted by rising ratesJuly 2025 Update & Consistent Return Investment Signals - خودرو بانک
Tools to assess Pacira BioSciences Inc.’s risk profileBear Alert & Risk Managed Investment Strategies - Newser
Technical signs of recovery in Pacira BioSciences Inc.Fed Meeting & Comprehensive Market Scan Reports - Newser
Pacira BioSciences: Corporate Governance Reforms and Executive Compensation Alignment in 2025 - AInvest
Does Pacira BioSciences Inc. have strong fundamentalsJuly 2025 Earnings & Fast Moving Trade Plans - خودرو بانک
Pacira BioSciences reports inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener
Pacira (PCRX) BioSciences Announces Inducement Awards to New Emp - GuruFocus
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listin - GuruFocus
Pacira BioSciences’ Strategic Use of Equity Incentives to Fuel Growth - AInvest
Pacira BioSciences grants inducement awards to nine new employees. - AInvest
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
31.1K Shares Worth of Equity Awards: Pacira BioSciences Strengthens Team with Nine Strategic Hires - Stock Titan
Visual trend scoring systems applied to Pacira BioSciences Inc.July 2025 Outlook & Consistent Profit Alerts - Newser
Detecting price anomalies in Pacira BioSciences Inc. with AIInflation Watch & Target Return Focused Picks - Newser
Live market analysis of Pacira BioSciences Inc.Treasury Yields & Long-Term Growth Plans - Newser
Trend analysis for Pacira BioSciences Inc. this weekTrade Entry Report & Real-Time Stock Movement Alerts - Newser
Pacira BioSciences Inc. stock prediction for this weekEarnings Recap Report & Entry Point Confirmation Alerts - Newser
Does Pacira BioSciences Inc. have declining or rising EPSJuly 2025 Snapshot & Weekly High Return Stock Forecasts - خودرو بانک
Can Pacira BioSciences Inc. grow without external funding2025 Short Interest & AI Based Buy and Sell Signals - خودرو بانک
Does Pacira BioSciences Inc. fit your quant trading modelWeekly Stock Report & Low Risk High Win Rate Stock Picks - Newser
What are Pacira BioSciences Inc.’s earnings expectationsJuly 2025 PreEarnings & Short-Term High Return Strategies - خودرو بانک
Using flow based indicators on Pacira BioSciences Inc.Market Rally & Fast Exit Strategy with Risk Control - Newser
Best data tools to analyze Pacira BioSciences Inc. stockM&A Rumor & Safe Swing Trade Setups - Newser
Risk adjusted return profile for Pacira BioSciences Inc. analyzedJuly 2025 Gainers & Safe Capital Growth Stock Tips - Newser
What data driven models say about Pacira BioSciences Inc.’s future2025 Investor Takeaways & Capital Efficiency Focused Strategies - Newser
Institutional scanner results for Pacira BioSciences Inc.July 2025 Sentiment & AI Driven Stock Price Forecasts - Newser
Exit strategy if you’re trapped in Pacira BioSciences Inc.July 2025 Spike Watch & Precise Swing Trade Entry Alerts - Newser
Pacira BioSciences Inc. stock trend forecastJuly 2025 Big Picture & Low Drawdown Trading Techniques - Newser
Reversal indicators forming on Pacira BioSciences Inc. stockQuarterly Portfolio Summary & Daily Stock Trend Watchlist - Newser
Candlestick signals on Pacira BioSciences Inc. stock todayShare Buyback & Verified Trade Idea Suggestions - Newser
Has Pacira BioSciences Inc. formed a bullish divergenceJuly 2025 Spike Watch & Community Consensus Trade Signals - Newser
Published on: 2025-09-03 02:53:04 - Newser
Is Pacira BioSciences Inc. stock a value trapQuarterly Trade Summary & Consistent Growth Equity Picks - خودرو بانک
Signal strength of Pacira BioSciences Inc. stock in tech scannersEarnings Performance Report & Weekly Sector Rotation Insights - Newser
How to forecast Pacira BioSciences Inc. trends using time seriesJuly 2025 Levels & Risk Controlled Daily Plans - Newser
Will Pacira BioSciences Inc. rebound enough to break evenJuly 2025 Snapshot & High Accuracy Trade Alerts - Newser
Published on: 2025-09-02 23:10:17 - Newser
Is Pacira BioSciences Inc. subject to activist investor interestPortfolio Update Report & Daily Entry Point Alerts - خودرو بانک
Is Pacira BioSciences Inc. a strong growth stock2025 Volume Leaders & High Yield Equity Trading Tips - خودرو بانک
Risk vs reward if holding onto Pacira BioSciences Inc.Weekly Gains Report & Community Verified Trade Alerts - Newser
Pacira BioSciences Rises 0.07% on Strong Earnings - AInvest
Pacira Biosciences Inc (PCRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Pacira Biosciences Inc 주식 (PCRX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| BIGAL MARCELO | Director |
Aug 07 '25 |
Sale |
23.67 |
4,912 |
116,267 |
11,393 |
3.53%
자본화:
|
볼륨(24시간):